Regis [RGS] vs Medifast [MED] Detailed Stock Comparison

Regis Corporation

NASDAQ
Loading...

Medifast Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Regis Corporation wins in 16 metrics, Medifast Inc. wins in 3 metrics, with 0 ties. Regis Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Regis Corporation Medifast Inc. Better
P/E Ratio (TTM) 0.61 531.50 Regis Corporation
Price-to-Book Ratio 0.37 0.57 Regis Corporation
Debt-to-Equity Ratio 182.32 5.38 Medifast Inc.
PEG Ratio -0.01 -0.22 Regis Corporation
EV/EBITDA 14.73 -1,469.18 Regis Corporation
Profit Margin (TTM) 50.79% -4.84% Regis Corporation
Operating Margin (TTM) 10.85% -10.39% Regis Corporation
EBITDA Margin (TTM) 10.85% N/A N/A
Return on Equity 94.31% -9.13% Regis Corporation
Return on Assets (TTM) 2.60% -3.34% Regis Corporation
Free Cash Flow (TTM) $12.45M $1.25M Regis Corporation
1-Year Return 29.78% -10.95% Regis Corporation
Price-to-Sales Ratio (TTM) 0.30 0.32 Regis Corporation
Enterprise Value $394.59M $-42.61M Regis Corporation
EV/Revenue Ratio 1.69 -0.11 Regis Corporation
Gross Profit Margin (TTM) 36.51% 69.43% Medifast Inc.
Revenue per Share (TTM) $96 $35 Regis Corporation
Earnings per Share (Diluted) $44.99 $-1.70 Regis Corporation
Beta (Stock Volatility) 1.40 0.56 Medifast Inc.
Short % of Float 2.55% 19.31% Regis Corporation

Regis Corporation vs Medifast Inc. Stock Performance Analysis

Loading Price Chart...

RGS
MED

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Regis Corporation1.67%-5.83%3.23%23.32%-5.15%2.66%
Medifast Inc.0.25%-6.69%15.43%14.57%12.98%17.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Regis Corporation29.78%28.36%-84.83%-88.92%97.62%-19.75%
Medifast Inc.-10.95%-85.01%-95.99%-61.95%-51.02%-36.36%

Performance & Financial Health Analysis: Regis Corporation vs Medifast Inc.

MetricRGSMED
Market Information
Market Cap i$67.69M$121.13M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i12,344240,387
90 Day Avg. Volume i10,715275,592
Last Close$27.45$12.27
52 Week Range$18.20 - $31.50$9.22 - $15.46
% from 52W High-12.86%-20.63%
All-Time High$465.40 (Oct 28, 2019)$336.99 (May 24, 2021)
% from All-Time High-94.10%-96.36%
Growth Metrics
Quarterly Revenue Growth0.22%-0.37%
Quarterly Earnings Growth-0.94%-0.37%
Financial Health
Profit Margin (TTM) i0.51%-0.05%
Operating Margin (TTM) i0.11%-0.10%
Return on Equity (TTM) i0.94%-0.09%
Debt to Equity (MRQ) i182.325.38
Cash & Liquidity
Book Value per Share (MRQ)$75.52$19.29
Cash per Share (MRQ)$7.36$16.22
Operating Cash Flow (TTM) i$16.90M$6.86M
Levered Free Cash Flow (TTM) i$6.72M$5.41M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00$0.00

Valuation & Enterprise Metrics Analysis: Regis Corporation vs Medifast Inc.

MetricRGS (Apr 24, 2026)MED (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i0.61531.50
Forward P/E i-10.45-4.00
PEG Ratio i-0.01-0.22
Price to Sales (TTM) i0.300.32
Price to Book (MRQ) i0.370.57
Market Capitalization
Market Capitalization i$67.69M$121.13M
Enterprise Value i$394.59M$-42,606,284
Enterprise Value Metrics
Enterprise to Revenue i1.69-0.11
Enterprise to EBITDA i14.73-1,469.18
Risk & Other Metrics
Beta i1.400.56
Book Value per Share (MRQ) i$75.52$19.29

Financial Statements Comparison: Regis Corporation vs Medifast Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricRGS (2025)MED (2025)
Revenue/Sales i210.13M385.79M
Cost of Goods Sold i129.63M110.60M
COGS % of Revenue i61.7%28.7%
Gross Profit i80.51M275.19M
Gross Margin i38.3%71.3%
Research & Development iN/AN/A
Operating Income (EBIT) i20.29M-14.21M
Operating Margin i9.7%-3.7%
EBITDA i25.11M29,000
EBITDA Margin i11.9%0.0%
Pre-Tax Income i1.54M-5.64M
Pre-Tax Income % of Revenue i0.7%-1.5%
Income Tax i-115.50M13.03M
Income Tax % of Revenue i-55.0%3.4%
Net Income (Profit) i123.54M-18.67M
Profit Margin i58.8%-4.8%

Balance Sheet & Liquidity Metrics

MetricRGS (2025)MED (2025)
Cash & Equivalents i16.96M89.30M
Total Current Assets i50.48M201.68M
Total Current Assets % of Revenue i24.0%52.3%
Total Current Liabilities i101.69M42.96M
Total Current Liabilities % of Revenue i48.4%11.1%
Long-Term Debt i288.97MN/A
Long-Term Debt % of Revenue i137.5%0.0%
Total Shareholders Equity i185.62M198.92M
Retained Earnings i101.97M158.27M
Retained Earnings % of Revenue i48.5%41.0%
Property, Plant & Equipment i229.86M7.23M

Cash Flow Statement Comparison

MetricRGS (2025)MED (2025)
Operating Cash Flow i27.08M8.92M
Operating Cash Flow % of Revenue i12.9%2.3%
Capital Expenditures iN/A-5.61M
Free Cash Flow i12.45M1.25M
FCF Margin i5.9%0.3%
Debt Repayment i-14.66MN/A
Common Stock Repurchase iN/A-369,000

Short Interest & Institutional Ownership Analysis

MetricRGSMED
Shares Short i54,5612.06M
Short Ratio i5.897.14
Short % of Float i2.55%19.31%
Shares Outstanding i2.50M10.99M
Float Shares i2.38M8.48M
% Held by Insiders i15.13%3.86%
% Held by Institutions i30.81%78.14%
% Held by Public i54.06%18.00%

Dividend Analysis & Yield Comparison: Regis Corporation vs Medifast Inc.

MetricRGSMED
Last 12-Month Dividend i$0.00$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00$2.74
3-Year Avg Dividend Yield iN/A1.43%
3-Year Total Dividends i$0.00$8.22
Ex-Dividend DateN/AJun 26, 2023